Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 19:22:26 UTC |
---|
Update Date | 2021-09-26 23:14:52 UTC |
---|
HMDB ID | HMDB0258155 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide |
---|
Description | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide, also known as (2-(4-(2-benzimidazol-2ylthio)ethyl)piperazin-1yl)-N-(2,4-bis(methylthio)-6-methyl-3-pyridyl)acetamide or K604 compound, belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Based on a literature review very few articles have been published on 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-[4-[2-(1h-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-n-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2)CC1 InChI=1S/C23H30N6OS3/c1-16-14-19(31-2)21(22(24-16)32-3)27-20(30)15-29-10-8-28(9-11-29)12-13-33-23-25-17-6-4-5-7-18(17)26-23/h4-7,14H,8-13,15H2,1-3H3,(H,25,26)(H,27,30) |
---|
Synonyms | Value | Source |
---|
2-[4-[2-(1H-Benzimidazol-2-ylsulphanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulphanyl)pyridin-3-yl]acetamide | Generator | 2-{4-[2-(1H-1,3-benzodiazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]ethanimidate | HMDB | 2-{4-[2-(1H-1,3-benzodiazol-2-ylsulphanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulphanyl)pyridin-3-yl]ethanimidate | HMDB | 2-{4-[2-(1H-1,3-benzodiazol-2-ylsulphanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulphanyl)pyridin-3-yl]ethanimidic acid | HMDB | (2-(4-(2-Benzimidazol-2ylthio)ethyl)piperazin-1yl)-N-(2,4-bis(methylthio)-6-methyl-3-pyridyl)acetamide | HMDB | 2-(4-(2-(Benzimidazol-2- ylthio)ethyl)piperazin-1-yl)-N-(2,4- bis(methylthio)-6-methyl-3-pyridyl)acetamide | HMDB | 2-(4-(2-(Benzimidazol-2-ylthio)ethyl)piperazin-1-yl)-N-(2,4-bis(methylthio)-6-methyl-3-pyridyl)acetamide | HMDB | K604 Compound | HMDB |
|
---|
Chemical Formula | C23H30N6OS3 |
---|
Average Molecular Weight | 502.71 |
---|
Monoisotopic Molecular Weight | 502.164323132 |
---|
IUPAC Name | 2-{4-[2-(1H-1,3-benzodiazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide |
---|
Traditional Name | 2-{4-[2-(1H-1,3-benzodiazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2)CC1 |
---|
InChI Identifier | InChI=1S/C23H30N6OS3/c1-16-14-19(31-2)21(22(24-16)32-3)27-20(30)15-29-10-8-28(9-11-29)12-13-33-23-25-17-6-4-5-7-18(17)26-23/h4-7,14H,8-13,15H2,1-3H3,(H,25,26)(H,27,30) |
---|
InChI Key | VGGMTOYKEDKFLN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- N-piperazineacetamide
- Benzimidazole
- Aryl thioether
- N-arylamide
- Methylpyridine
- Alkylarylthioether
- N-alkylpiperazine
- 1,4-diazinane
- Benzenoid
- Piperazine
- Pyridine
- Azole
- Heteroaromatic compound
- Imidazole
- Carboxamide group
- Tertiary aliphatic amine
- Secondary carboxylic acid amide
- Tertiary amine
- Sulfenyl compound
- Organoheterocyclic compound
- Azacycle
- Thioether
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Carbonyl group
- Organic oxide
- Amine
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C | 4303.2 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C | 3825.5 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C | 6034.0 | Standard polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1 | 4495.0 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1 | 3725.2 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1 | 6470.1 | Standard polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1)[Si](C)(C)C | 4375.3 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1)[Si](C)(C)C | 3756.1 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C)CC1)[Si](C)(C)C | 5622.7 | Standard polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C(C)(C)C | 4502.1 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C(C)(C)C | 3970.4 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3[NH]2)CC1)[Si](C)(C)C(C)(C)C | 6002.0 | Standard polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1 | 4619.1 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1 | 3902.3 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,1TBDMS,isomer #2 | CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1 | 6410.4 | Standard polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1)[Si](C)(C)C(C)(C)C | 4645.9 | Semi standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1)[Si](C)(C)C(C)(C)C | 4038.5 | Standard non polar | 33892256 | 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide,2TBDMS,isomer #1 | CSC1=CC(C)=NC(SC)=C1N(C(=O)CN1CCN(CCSC2=NC3=CC=CC=C3N2[Si](C)(C)C(C)(C)C)CC1)[Si](C)(C)C(C)(C)C | 5559.1 | Standard polar | 33892256 |
| Show more...
---|